abstract |
An amount of vascular hyperpermeability inhibitor of a compound selected from danazol and pharmaceutically acceptable salts of danazol for use in the treatment of a disease or condition mediated by vascular hyperpermeability in an animal in need thereof, in which the disease or condition is hypertension. |